EFFICACY OF 5-AZACITIDINE IN THE TREATMENT OF HIGHER-RISK MYELODISPLASTIC SYNDROMES, ACUTE MYELOID LEUKEMIA AND CHRONIC MYELOMONOCYTIC LEUKEMIA: EXPERIENCE AT A SINGLE CENTER

被引：0
|
作者：
Vazquez, H. Hernandez [1 ]
Diez, E. Amutio [1 ]
Eizaguirre, I. Olazabal [1 ]
Malcorra, A. Balerdi [1 ]
Urkixo, I. Etxeguren [1 ]
Iruin, A. Uresandi [1 ]
Pomposo, M. Puente [1 ]
Usategui, M. Duenas [1 ]
Mazon, J. Mateos [1 ]
Perez, A. Iglesias [1 ]
Quintana, A. Moreto [1 ]
Frances, M. A. Pinan [1 ]
Goni, F. Floristan [1 ]
Martinez, M. C. Alvarez [1 ]
Ontoria, I. Hernandez [1 ]
Garcia-Ruiz, J. C. [1 ]
机构：
[1] Hosp Cruces, Baracaldo, Spain
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1405
引用
收藏
页码：564 / 565
页数：2
相关论文
共 50 条
  • [21] Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia
    Voso, Maria Teresa
    Breccia, Massimo
    Lunghi, Monia
    Poloni, Antonella
    Niscola, Pasquale
    Finelli, Carlo
    Bari, Alessia
    Musto, Pellegrino
    Zambello, Renato
    Fianchi, Luana
    Alimena, Giuliana
    Leone, Giuseppe
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2013, 90 (04) : 345 - 348
  • [22] INFECTIOUS COMPLICATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES/ACUTE MYELOID LEUKEMIA TREATED WITH 5-AZACITIDINE
    Ramos, S.
    Santos, M.
    Tenreiro, R.
    Pereira, M.
    Cortesao, E.
    Rito, L.
    Ribeiro, M. L.
    HAEMATOLOGICA, 2015, 100 : 474 - 475
  • [23] ACUTE MYELOID LEUKEMIA WITH INV(16) TO TREATMENT WITH 5-AZACITIDINE ON THE BASIS OF A CASE
    Lopez Diaz, M.
    Cuenca Aprell, C. A.
    Iglesias Varela, R.
    Albors Ferreiro, M.
    Sastre Moral, J. L.
    HAEMATOLOGICA, 2017, 102 : 166 - 167
  • [24] Pevonedistat plus azacitidine versus azacitidine alone in patients with higher-risk myelodysplastic syndromes/chronic myelomonocytic leukemia or low-blast acute myelogenous leukemia: a phase 2 randomized study
    Ades, Lionel
    Watts, Justin
    Radinoff, Atanas
    Arnan Sangerman, Montserrat
    Cerrano, Marco
    Font Lopez, Patricia
    Zeidner, Joshua F.
    Diez Campelo, Maria
    Graux, Carlos
    Liesveld, Jane
    Selleslag, Dominik
    Tzvetkov, Nikolay
    Fram, Robert J.
    Zhao, Dan
    Bell, Jill
    Friedlander, Sharon
    Faller, Douglas V.
    Sekeres, Mikkael A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 6 - 7
  • [25] Randomized Phase 2 Trial of Pevonedistat Plus Azacitidine Versus Azacitidine in Higher-Risk Myelodysplastic Syndromes/Chronic Myelomonocytic Leukemia or Low-Blast Acute Myeloid Leukemia: Exploratory Analysis of Patient-Reported Outcomes
    Zeidner, Joshua F.
    Mazerolle, Flora
    Bell, Jill A.
    Cain, Lauren E.
    Faller, Douglas V.
    Dalal, Mehul
    Regnault, Antoine
    Fram, Robert J.
    BLOOD, 2020, 136
  • [26] Patient Perspectives on Symptom Experience and Impact on Health-Related Quality of Life in Higher-Risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Low-Blast Acute Myeloid Leukemia
    Bell, Jill A.
    Galaznik, Aaron
    Pompilus, Farrah A.
    Strzok, Sara
    Fram, Robert J.
    Faller, Douglas V.
    Marquis, Patrick
    BLOOD, 2017, 130
  • [27] RESULTS OF THE USE OF 5-AZACITIDINE IN OLD PATIENTS DIAGNOSED OF CHRONIC MYELOMONOCYTIC LEUKEMIA
    Llorente Dunia, De Miguel
    Lopez Nuria, Golbano
    Morfa Miguel, Diaz
    Juanis Jaime, Arbeteta
    Sanz Dolores, Morales
    Martin Sonia, Herreo
    Perez Dolores, Subira
    Albiz Blanca, Pinedo
    HAEMATOLOGICA, 2016, 101 : 344 - 344
  • [28] Response to azacitidine is independent of TP53 mutations in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia
    Mueller-Thomas, C.
    Rudelius, M.
    Wolf, P.
    Schanz, J.
    Schmidt, B.
    Platzbecker, U.
    Germing, U.
    Peschel, C.
    Goetze, K.
    LEUKEMIA RESEARCH, 2013, 37 : S73 - S74
  • [29] Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia
    Mueller-Thomas, Catharina
    Rudelius, Martina
    Rondak, Ina-Christine
    Haferlach, Torsten
    Schanz, Julie
    Huberle, Christina
    Schmidt, Burkhard
    Blaser, Rainer
    Kremer, Marcus
    Peschel, Christian
    Germing, Ulrich
    Platzbecker, Uwe
    Goetze, Katharina
    HAEMATOLOGICA, 2014, 99 (10) : E179 - E181
  • [30] The Safety and Tolerability of Azacitidine (AZA) Are Comparable in Patients with Acute Myeloid Leukemia (AML) or Higher-Risk Myelodysplastic Syndromes (MDS)
    Seymour, John F.
    Silverman, Lewis R.
    Doehner, Hartmut
    Fenaux, Pierre
    Mufti, Ghulam J.
    Santini, Valeria
    Minden, Mark D.
    Stone, Richard M.
    Lucy, Lela M.
    Songer, Stephen
    Dougherty, Donna
    Hinkle, Randy
    Gambini, Dominique
    Beach, C. L.
    Dombret, Herve
    BLOOD, 2015, 126 (23)
12345